Newsletter Xeltis passes halfway point in pivotal US trial, but regenerative vascular technology still has something to prove Phillip Papadimitri July 15 2026
Newsletter A Congress Full of Connection, Innovation and Perspective by Phillip Papadimitri July 15 2026
Newsletter Medtronic Backs Anteris with a $90M Strategic Investment by Phillip Papadimitri July 15 2026
Newsletter Xeltis passes halfway point in pivotal US trial, but regenerative vascular technology still has something to prove by Phillip Papadimitri July 15 2026
Newsletter A Congress Full of Connection, Innovation and Perspective by Phillip Papadimitri July 15 2026
Newsletter Medtronic Backs Anteris with a $90M Strategic Investment by Phillip Papadimitri July 15 2026
Newsletter Xeltis passes halfway point in pivotal US trial, but regenerative vascular technology still has something to prove Phillip Papadimitri July 15 2026
Newsletter A Congress Full of Connection, Innovation and Perspective by Phillip Papadimitri July 15 2026
Newsletter Medtronic Backs Anteris with a $90M Strategic Investment by Phillip Papadimitri July 15 2026
Newsletter EU TAVI Market 2026: Growth, Competition, and the Rise of New Challengers by Paul White July 10 2026
Newsletter Ahead of SRS 2026: Surgical Robotics & AI, What Happens After Approval? by Liam Newton June 26 2026
Xeltis passes halfway point in pivotal US trial, but regenerative vascular technology still has something to prove Phillip Papadimitri July 15 2026 Newsletter
A Congress Full of Connection, Innovation and Perspective Phillip Papadimitri July 15 2026 Newsletter
EU TAVI Market 2026: Growth, Competition, and the Rise of New Challengers Paul White July 10 2026 Newsletter
Ahead of SRS 2026: Surgical Robotics & AI, What Happens After Approval? Liam Newton June 26 2026 Newsletter
10 Years ago there were only 2 treatment options for Prostate Cancer Tim Lawrie March 10 2026 Newsletter
Why Radiology AI Needs Orchestration, Not More Algorithms Scanning The Market February 19 2026 Podcast
Navigating hospital politics, workflows, and entering the US market with Thomas Bertinotti Scanning The Market February 19 2026 Podcast
The Long Game in HealthTech: Riverain CEO Steve Worrell on Growth Without Burnout Scanning The Market February 19 2026 Podcast
Building Teams and Tech That Scale: Jina Park on AI, Growth, and Grit Scanning The Market February 19 2026 Podcast
Edwards’ request for broader TAVR Medicare coverage gets pushback News & Insights February 5 2026 Cardiology
J&J corrects Impella heart pumps issue linked to 22 serious injuries News & Insights February 5 2026 Cardiology
Xeltis passes halfway point in pivotal US trial, but regenerative vascular technology still has something to prove July 15 2026
